Publication CHEMOPROPHYLAXIS VERSUS IMMUNOPROPHYLAXIS IN TUBERCULOSIS AND LEPROSY INFECTION Novita BD. Jurnal Widya Medika. 2020; 6 (1) : 65-71.
Publication Anti-Leprosy Vaccine (Hansen’s Disease Vaccine) Packyanathan J, Packyanathan I. Springer. Advances in Pharmaceutical Biotechnology. 2020;
Publication Leprosy: Treatment and Management of Complications. Maymone M, Venkatesh S, Laughter M, et al. Journal of the American Academy of Dermatology. 2020;
Publication Preventing Leprosy: Epidemiological and immunological aspects of chemo- and immunoprophylaxis in leprosy patients’ contacts Richardus R. Leiden University. Leiden University of Medical Center. 2020; Download PDF
Publication BCG: a vaccine with multiple faces. Yamazaki-Nakashimada M, Unzueta A, Gámez-González L, et al. Human vaccines & immunotherapeutics. 2020;
Publication Prevention of transmission of leprosy: The current scenario. Palit A, Kar H. Indian journal of dermatology, venereology and leprology. 2020; 86 (2) : 115-123. Download PDF
Publication A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults. Duthie MS, Frevol A, Day T, et al. Vaccine. 2019;
Publication Protective efficacy of BCG against leprosy in Northern Malawi. Fine PE, Ponnighaus J M, Maine N, et al. Lancet. 1986; 2 (8505) : 499-502. Download PDF
